Nvidia Gains Trail Chip Sector as AI Investment Focus Shifts
Technology Sarah Chen

Nvidia Gains Trail Chip Sector as AI Investment Focus Shifts

Nvidia shares advanced 2.9% last week but underperformed the broader chip index, as Alphabet's $15B capex boost and AMD's Anthropic deal signal a rotation in AI investment.

NVDA GOOGL AMD MU MSFT META AMZN
Wearable Devices Shares Surge on Massive Trading Volume
Markets Daniel Marsh

Wearable Devices Shares Surge on Massive Trading Volume

Wearable Devices Ltd. saw its stock price surge 50.7% on Thursday, with trading volume reaching 11.5 times the total share count. Premarket activity remains elevated.

WLDS
UK Banks Surge as Retail Sales Beat Forecasts, FTSE 100 Gains
Markets Daniel Marsh

UK Banks Surge as Retail Sales Beat Forecasts, FTSE 100 Gains

The FTSE 100 advanced as banking shares outpaced retailers after UK retail sales unexpectedly rose 1.0% in June, defying forecasts of a decline.

HSBC TSCO NXT JD BP SHEL
Lloyds shares inch up as buyback costs rise ahead of strategy update
Markets Daniel Marsh

Lloyds shares inch up as buyback costs rise ahead of strategy update

Lloyds shares rose 0.9% to 113.42p, but higher buyback costs underscore the need for a strong strategy update on July 30.

AT&T's Buyback Efficiency Improves as Stock Dips Below H1 Average Cost
Markets Daniel Marsh

AT&T's Buyback Efficiency Improves as Stock Dips Below H1 Average Cost

AT&T's stock dip below the first-half average buyback price of $25.49 enhances repurchase efficiency, with $5.57B remaining in the program.

T TMUS VZ
Tesla Faces $16.7 Billion Capex Surge in Second Half of 2026
Earnings James Calloway

Tesla Faces $16.7 Billion Capex Surge in Second Half of 2026

Tesla's capital expenditures surged to $5.79 billion in Q2 2026, driving negative free cash flow of $1.09 billion. The company projects over $25 billion in capex for the full year.

TSLA
Hims & Hers Peptide Opportunity Tempered by FDA Timeline
Regulation James Calloway

Hims & Hers Peptide Opportunity Tempered by FDA Timeline

Hims & Hers (HIMS) rose 3.4% after FDA advisers supported four unapproved peptides for compounding, but the final rule may take up to a year. Analysts estimate $440M in peptide sales by 2027.

HIMS
SAP Shares Surge 6% on Cloud Backlog Strength, Despite Profit Outlook Cut
Earnings James Calloway

SAP Shares Surge 6% on Cloud Backlog Strength, Despite Profit Outlook Cut

SAP shares rose 6.2% as cloud backlog growth of 26% exceeded forecasts, outweighing a reduced profit outlook. Market value increased by €9.8 billion.

SAP
Lockheed Martin Surges 10.5% on Raised Free Cash Flow Outlook and Record Backlog
Earnings James Calloway

Lockheed Martin Surges 10.5% on Raised Free Cash Flow Outlook and Record Backlog

Lockheed Martin (LMT) shares surged 10.5% after raising its 2026 free cash flow midpoint by $450 million, driven by a $450 million reduction in capital spending. Backlog hit a record $230.4 billion.

LMT RTX GD
Oracle Stock Gains 2.5% on $7 Billion Pentagon Contract Despite Valuation Disparity
Technology Sarah Chen

Oracle Stock Gains 2.5% on $7 Billion Pentagon Contract Despite Valuation Disparity

Oracle shares climbed 2.5% after-hours on a $7 billion Pentagon software contract, though the implied equity gain of $8.6 billion far exceeds the deal's maximum value, suggesting relief buying.

ORCL MSFT
Intel Surges on AI Server Profit Surge; 79% Incremental Margin
Earnings James Calloway

Intel Surges on AI Server Profit Surge; 79% Incremental Margin

Intel shares rose nearly 4% premarket after Q2 earnings beat, driven by a 79% incremental margin in data-center and AI revenue, which surged 59%.

INTC MSFT META
Nu Holdings Shifts Focus to Deposits Ahead of Mexico Bank Launch
Markets Daniel Marsh

Nu Holdings Shifts Focus to Deposits Ahead of Mexico Bank Launch

Nu Holdings (NYSE:NU) is set to launch banking services in Mexico on August 6, emphasizing deposit growth over customer acquisition.

NU